Previous 10 | Next 10 |
2023-03-23 16:25:27 ET Nyxoah ( NASDAQ: NYXH ) said Thursday it announced a €13.35 million private placement financing. The company expects to raise the proceeds through sale of 2,047,544 new ordinary shares at a price per share of €6.52. The proceeds fr...
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces a $ 15 Million Private Placement Financing Mont-Saint-Guibert, Belgium – March 23, 2023, 9:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” ...
2023-03-23 03:15:55 ET Nyxoah press release ( NASDAQ: NYXH ): Q4 GAAP EPS of -€0.51. Revenue of €1.31M (+336.7% Y/Y). For further details see: Nyxoah GAAP EPS of -€0.51, revenue of €1.31M
2023-03-22 21:26:04 ET Nyxoah S.A. (NYXH) Q4 2022 Earnings Conference Call March 22, 2023, 4:30 PM ET Company Participants Olivier Taelman - Chief Executive Officer Loïc Moreau - Chief Financial Officer Conference Call Participants Adam Maeder - PSC ...
REGULATED INFORMATION Nyxoah Reports Fourth Q uarter and Full Year 202 2 Financial and Operating Results Completed all 115 implants in the DREAM U.S . pivotal study Mont-Saint-Guibert, Belgium – M...
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 Mont-Saint-Guibert, Belgium – March 8, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a me...
Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference Mont-Saint-Guibert, Belgium – March 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology compan...
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones All 115 patients implanted in DREAM U.S. pivotal study First DREAM PMA module submitted First patient implanted in ACCCESS U.S. pivotal study Mon...
Nyxoah Announces Inaugural Investor & Analyst Meeting Mont-Saint-Guibert, Belgium – February 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on ...
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors Mont-Saint-Guibert, Belgium – January 9, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on...
News, Short Squeeze, Breakout and More Instantly...
Nyxoah Appoints Scott Holstine as Chief Commercial Officer Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the ...
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (&...
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024 , 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the develop...